Topics

The top 5 most promising drugs (February 2014) Drugs

01:39 EDT 2nd April 2020 | BioPortfolio

Non-medicated valchlor demonstration [actelion pharmaceuticals us, inc.]

Non-medicated VALCHLOR Demonstration Gel

Valchlor [actelion pharmaceuticals us, inc.]

These highlights do not include all the information needed to use VALCHLOR safely and effectively. See full prescribing information for VALCHLOR. VALCHLOR (mechlorethamine) gel, for topical use Initial U.S. Approval: 1949

Opsumit [actelion pharmaceuticals us, inc.]

These highlights do not include all the information needed to use OPSUMIT safely and effectively. See full prescribing information for OPSUMIT.   OPSUMIT (macitentan) tablets, for oral use Initial U.S. Approval: 2013

Valchlor [helsinn therapeutics (u.s.), inc.]

These highlights do not include all the information needed to use VALCHLOR safely and effectively. See full prescribing information for VALCHLOR. VALCHLOR (mechlorethamine) gel, for topical use Initial U.S. Approval: 1949

Recombinate [baxter healthcare corporation]

RECOMBINATE [Antihemophilic Factor (Recombinant)]

Recombinate [baxter healthcare corporation]

RECOMBINATE [Antihemophilic Factor (Recombinant)]

Recombinate [baxter healthcare corporation]

RECOMBINATE [Antihemophilic Factor (Recombinant)]

Quick Search

review and buy The top 5 most promising drugs (February 2014) market research data and corporate reports here